Skip to main content
. 2022 Dec 19;2(12):1657–1667. doi: 10.1158/2767-9764.CRC-22-0388

FIGURE 1.

FIGURE 1

Study design. Dogs diagnosed with a histologically confirmed glioma were selected for inclusion into the trial. A total of 10 dogs were enrolled and received daily losartan plus daily propranolol with biweekly vaccination for the first 10 weeks then monthly through the duration of survival. After the first 10 weeks, blood collection and MRI was completed every three months throughout the duration of the study. Following death, a necropsy was completed.